{"DataElement":{"publicId":"2974448","version":"1","preferredName":"Patient Central Nervous System Disease or Disorder Eligibility Determination Ind-2","preferredDefinition":"the yes/no indicator related to eligibility criteria for a person who receives medical treatment having disease related to the brain and spinal cord.","longName":"2974446v1.0:2018257v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2974446","version":"1","preferredName":"Patient Central Nervous System Disease or Disorder Eligibility Determination","preferredDefinition":"information related to eligibility criteria for person who receives medical attention, care, or treatment having disease related to the brain and spinal cord.","longName":"2233604v1.0:2974444v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2974478","version":"1","preferredName":"Central Nervous System Disease or Disorder Eligibility Determination","preferredDefinition":"The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Criteria to determine eligibility of patients for medical care programs and services.","longName":"C12438:C2991:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F208-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD9A2C7-351D-7BDB-E040-BB89AD432FAC","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104889","version":"1","longName":"GOG-0229K","context":"NRG"},{"publicId":"4104903","version":"1","longName":"GOG-0170R","context":"NRG"},{"publicId":"10000427","version":"1","longName":"GOG-0170R","context":"NRG"},{"publicId":"10000426","version":"1","longName":"GOG-0170R","context":"NRG"},{"publicId":"4104890","version":"1","longName":"GOG-0229L","context":"NRG"},{"publicId":"4104893","version":"1","longName":"GOG-0230D","context":"NRG"},{"publicId":"4104897","version":"1","longName":"GOG-0250","context":"NRG"},{"publicId":"10000081","version":"1","longName":"GOG-0186J","context":"NRG"},{"publicId":"4104906","version":"1","longName":"GOG-0186J","context":"NRG"},{"publicId":"10000082","version":"1","longName":"GOG-0186J","context":"NRG"},{"publicId":"10000346","version":"1","longName":"GOG-0186K","context":"NRG"},{"publicId":"10000345","version":"1","longName":"GOG-0186K","context":"NRG"},{"publicId":"4104907","version":"1","longName":"GOG-0186K","context":"NRG"},{"publicId":"10000430","version":"1","longName":"GOG-0186I","context":"NRG"},{"publicId":"10000429","version":"1","longName":"GOG-0186I","context":"NRG"},{"publicId":"4104905","version":"1","longName":"GOG-0186I","context":"NRG"},{"publicId":"4104891","version":"1","longName":"GOG-0229N","context":"NRG"},{"publicId":"4104883","version":"1","longName":"GOG-0240","context":"NRG"},{"publicId":"4104941","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"10000705","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"4104938","version":"1","longName":"GOG-0254","context":"NRG"},{"publicId":"4104892","version":"1","longName":"GOG-0229O","context":"NRG"},{"publicId":"4104916","version":"1","longName":"GOG-0257","context":"NRG"},{"publicId":"10000500","version":"1","longName":"GOG-0257","context":"NRG"},{"publicId":"10000499","version":"1","longName":"GOG-0257","context":"NRG"},{"publicId":"10000281","version":"1","longName":"GOG-0280","context":"NRG"},{"publicId":"10000282","version":"1","longName":"GOG-0280","context":"NRG"},{"publicId":"4104929","version":"1","longName":"GOG-0280","context":"NRG"}]},{"publicId":"4254096","version":"1","longName":"Protocol Phase","context":"PBTC","ClassificationSchemeItems":[{"publicId":"10000103","version":"1","longName":"Phase I","context":"PBTC"},{"publicId":"4254119","version":"1","longName":"PBTC-042","context":"PBTC"}]},{"publicId":"5999742","version":"1","longName":"CRF CDEs","context":"CITN","ClassificationSchemeItems":[{"publicId":"5999747","version":"1","longName":"Eligibility CDEs","context":"CITN"}]}],"AlternateNames":[{"name":"2974446v1.0:2018257v1.0","type":"USED_BY","context":"CTEP"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"PriCNSDx","type":"COG GDE Short Name","context":"COG"},{"name":"2974446v1.0:2018257v1.0","type":"USED_BY","context":"NRG"},{"name":"2974446v1.0:2018257v1.0","type":"USED_BY","context":"CITN"},{"name":"ABTC","type":"USED_BY","context":"ABTC"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"CNS_DZDR_IND","type":"OID, CCTG","context":"CCTG"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"2974446v1.0:2018257v1.0","type":"USED_BY","context":"CCTG"},{"name":"Alliance","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Does the patient have a histo","type":"Preferred Question Text","description":"Does the patient have a history or evidence upon physical examination of CNS disease, including primary brain tumor, seizures not controlled with standard medical therapy, any brain metastases, or history of cerebrovascular accident (CVA, stroke), transient ischemic attack (TIA) or subarachnoid hemorrhage within six months of the first date of treatment on this study","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Does the patient have a nervous system disorder (paresthesia, peripheral motor neuropathy, or peripheral sensory neuropathy) >= grade 2, per the CTCAE v4.0?","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Does the patient have a history or evidence upon physical examination of CNS disease, including primary brain tumor, seizures not controlled with standard medical therapy or any brain metastases?","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"A brain metastasis that is located <=5 mm of the optic chiasm or within the brainstem","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Does the patient have known brain metastases","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Does the patient have a history or evidence upon physical examination of CNS disease, including primary brain tumor, seizures which are not controlled with non-enzyme inducing anticonvulsants or any brain metastases?","url":null,"context":"CTEP"},{"name":"COG_CRF_Text_1","type":"Alternate Question Text","description":"Does patient have evidence of CNS disease at study enrollment","url":null,"context":"CTEP"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Does the patient have a history of seizure activity?","url":null,"context":"CTEP"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Does the patient have a history or evidence upon physical examination of CNS disease, including primary brain tumor, any CNS metastases, or history of cerebrovascular accident (CVA, stroke), transient ischemic attack (TIA) or subarachnoid hemorrhage within 6 months of the first date of treatment on this study? (Patients with CNS metastases must be stable for >3 months after treatment and off steroid treatment prior to study enrollment.)","url":null,"context":"CTEP"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Does patient have a prior history of CNS disease?","url":null,"context":"CTEP"},{"name":"CRF Text7","type":"Alternate Question Text","description":"Does the patient have a history or evidence upon physical exam of central nervous system (CNS) disease, including primary brain tumor, seizures not controlled with standard medical therapy or any brain metastases or leptomeningeal disease?","url":null,"context":"CTEP"},{"name":"CRf Text4","type":"Alternate Question Text","description":"No known CNS metastases or neurological symptoms possibly related to active CNS metastasis","url":null,"context":"CTEP"},{"name":"CRF Text10","type":"Alternate Question Text","description":"Does the patient have a history or evidence upon physical examination of CNS disease, including primary brain tumor, seizures not controlled with non-enzyme inducing anticonvulsants, any brain metastases and/or epidural disease, or history of cerebrovascular accident (CVA, stroke), transient ischemic attack (TIA) or subarachnoid hemorrhage within six months prior to the first date of study treatment?","url":null,"context":"CTEP"},{"name":"CRF Text9","type":"Alternate Question Text","description":"Does the patient have a history or evidence upon physical examination of CNS disease, including brain tumor, seizures not controlled with standard medical therapy or any brain metastases?","url":null,"context":"CTEP"},{"name":"CRF Text12","type":"Alternate Question Text","description":"Does the patient have symptomatic or untreated leptomeningeal or brain metastasis or spinal cord compression?","url":null,"context":"CTEP"},{"name":"AECC Text 1","type":"Alternate Question Text","description":"Patient has history of seizure disorder requiring antiepileptics and has had a seizure episode within the last 6 months","url":null,"context":"AECC"},{"name":"CRF Text13","type":"Alternate Question Text","description":"Does the patient have known leptomeningeal or brain metastases or spinal cord compression?","url":null,"context":"CTEP"},{"name":"CRF Text11","type":"Alternate Question Text","description":"Known central nervous system metastases","url":null,"context":"CTEP"},{"name":"CRF Text15","type":"Alternate Question Text","description":"Does patient have central nervous disease involvement?","url":null,"context":"CTEP"},{"name":"CRF Text 5","type":"Alternate Question Text","description":"History of epilepsy or other major central nervous system disorder","url":null,"context":"CTEP"},{"name":"CRF Text 16","type":"Alternate Question Text","description":"Known brain metastases (previously treated brain metastases, neurologically stable, and no ongoing or anticipated need for steroid therapy are eligible).","url":null,"context":"CTEP"},{"name":"NRG_CRF text","type":"Alternate Question Text","description":"Does the patient have known brain metastases or leptomeningeal metastases that does not meet the following conditions: metastases that have been treated and there is no MRI evidence of progression for at least 4 weeks after treatment is complete, no requirement for immunosuppressive doses of systemic corticosteroids (greater than 10 mg/day prednisone equivalents) for at least 2 weeks prior to study drug administration?","url":null,"context":"NRG"},{"name":"CRF Text 17","type":"Alternate Question Text","description":"Has known brain metastases and/or carcinomatous meningitis.","url":null,"context":"CTEP"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"Does patient have known active CNS metastases?","url":null,"context":"CTEP"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"Does patient have CNS disease or other sites of extra-pulmonary metastases at the time of most recent episode of disease recurrence preceding enrollment?","url":null,"context":"CTEP"},{"name":"COG CRF Text 18","type":"Alternate Question Text","description":"Does patient have a known CNS metastasis?","url":null,"context":"CTEP"},{"name":"COG CRF 19","type":"Alternate Question Text","description":"Does patient have no clinical signs or neurologic symptoms suggestive of CNS leukemia?","url":null,"context":"CTEP"},{"name":"ABTC 1501 Question","type":"Alternate Question Text","description":"Does the patient have a confirmed history of encephalitis, meningitis, or uncontrolled seizures within the year prior to signing informed consent?","url":null,"context":"ABTC"},{"name":"PBTC_Text1","type":"Alternate Question Text","description":"Does patient have recurrent, progressive or refractory diffuse intrinsic brain stem glioma (DIPG) or medulloblastoma or Atypical Teratoid Rhabdoid Tumor (ATRT)?","url":null,"context":"PBTC"},{"name":"CRF Text 20","type":"Alternate Question Text","description":"Does the patient have asymptomatic treated CNS disease","url":null,"context":"CTEP"},{"name":"CRF Text 21","type":"Alternate Question Text","description":"Radiographic demonstration of improvement upon the completion of CNS directed therapy and no evidence of interim progression between the completion of CNS directed therapy and the screening radiographic study","url":null,"context":"CTEP"},{"name":"COG_CRF_TEXT_22","type":"Alternate Question Text","description":"Does patient have symptomatic uncontrolled brain metastases","url":null,"context":"COG"},{"name":"COG_CRF_TEXT_2","type":"Alternate Question Text","description":"Has patient recovered to indicated level from nervous system disorders that resulted from prior therapy","url":null,"context":"COG"},{"name":"CITN-1","type":"Alternate Question Text","description":"Patient has known brain metastases and/or carcinomatous meningitis","url":null,"context":"CITN"},{"name":"CRF TEXT 22","type":"Alternate Question Text","description":"Does the patient have a history of seizure activity or a known condition that may pre- dispose to seizure activity?","url":null,"context":"NRG"},{"name":"CRF Text 23","type":"Alternate Question Text","description":"Does the patient have asymptomatic treated CNS metastases?","url":null,"context":"CTEP"},{"name":"EAE161","type":"Alternate Question Text","description":"Does patient have known untreated or symptomatic CNS metastasis?","url":null,"context":"ECOG-ACRIN"},{"name":"CE7","type":"Alternate Question Text","description":"The patients largest brain metastasis measures less than 2.5 cm in maximal diameter, and the total tumour volume is less than or equal to 30cm3","url":null,"context":"CCTG"},{"name":"CRF Text 24","type":"Alternate Question Text","description":"Does the patient have a history or evidence upon physical examination of CNS disease, including primary brain tumor, seizures which are not controlled with non-enzyme inducing anticonvulsants, and/or epidural disease, or history of cerebrovascular accident (CVA, stroke), transient ischemic attack (TIA) or subarachnoid hemorrhage within 6 months prior to the first date of study treatment?","url":null,"context":"CTEP"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"If yes, Are they stable (without evidence of progression by imaging using the identical imaging modality for each assessment, either magnetic resonance imaging [MRI] or computed tomography [CT] scan), for at least 4 weeks prior to study registration?","url":null,"context":"NRG"},{"name":"CRF Text 25","type":"Alternate Question Text","description":"Does the patient have a nervous system disorder (paresthesia, peripheral motor neuropathy, or peripheral sensory neuropathy) greater than or equal to grade 2, per the CTCAE v5.0?","url":null,"context":"CTEP"},{"name":"CRF Text26","type":"Alternate Question Text","description":"Untreated imminent or established spinal cord compression, treated with standard of care?","url":null,"context":"Alliance"},{"name":"NRG_eCRF_Text_2","type":"Alternate Question Text","description":"Does patient have brain metastases?","url":null,"context":"NRG"},{"name":"NRG_CRF_Text_3","type":"Alternate Question Text","description":"Does the patient have history of seizure disorder?","url":null,"context":"NRG"},{"name":"CRF Text 28","type":"Alternate Question Text","description":"Known Central Nervous System Metastases","url":null,"context":"Alliance"},{"name":"CRF Text29","type":"Alternate Question Text","description":"CNS metastasis","url":null,"context":"Alliance"},{"name":"CRF Text 30","type":"Alternate Question Text","description":"Does the patient have untreated brain metastases, spinal cord compression, or evidence of symptomatic brain metastases or leptomeningeal disease as noted on CT or MRI scans?","url":null,"context":"NRG"},{"name":"CRF Text27","type":"Alternate Question Text","description":"Does the patient have current symptoms from brain metastases?","url":null,"context":"Alliance"},{"name":"CRF TEXT 31","type":"Alternate Question Text","description":"FSRT target is at least 0.5 cm from the optic chiasm and brainstem","url":null,"context":"NRG"},{"name":"COG_CRF_Text_23","type":"Alternate Question Text","description":"Did patient have a history of CNS2 or CNS3 prior to disease confirmation?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Does the patient have brain tumors?","url":null,"context":"COG"},{"name":"NRG_eCRF_Text_1","type":"Alternate Question Text","description":"Does the patient have known brain metastases or leptomeningeal disease?","url":null,"context":"NRG"},{"name":"COG CRF Text 24","type":"Alternate Question Text","description":"Does the patient have a history of CNS metastases?","url":null,"context":"COG"},{"name":"CRF Text32","type":"Alternate Question Text","description":"Untreated spinal cord compression or evidence of spinal metastases with a risk of impending fracture or spinal cord compression?","url":null,"context":"Alliance"},{"name":"CRF Text 32","type":"Alternate Question Text","description":"Has the patient been treated for brain metastases?","url":null,"context":"NRG"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"Does patient CNS1, CNS2 or CNS3 disease without clinical signs or neurologic symptoms suggestive of CNS leukemia, such at facial nerve palsy, brain or eye involvement or hypothalamic syndrome?","url":null,"context":"COG"},{"name":"Alliance - 1","type":"Alternate Question Text","description":"Evidence of symptomatic CNS disease.","url":null,"context":"Alliance"},{"name":"COG CRF Text 6","type":"Alternate Question Text","description":"Does patient have known, untreated CNS metastases?","url":null,"context":"COG"},{"name":"COG CRF Text 33","type":"Alternate Question Text","description":"Has patient recovered to indicated level from nervous system disorders that resulted from prior therapy?","url":null,"context":"COG"},{"name":"COG CRF Text 34","type":"Alternate Question Text","description":"Does patient have a baseline neurological disorder with manifestations that overlap with vincristine-associated neurotoxicities?","url":null,"context":"COG"},{"name":"NRG_eCRF_Text_3","type":"Alternate Question Text","description":"Has the patient been treated for brain metastasis?","url":null,"context":"NRG"},{"name":"NRG_CRF_Text_","type":"Alternate Question Text","description":"Does the patient have treated brain metastases?","url":null,"context":"NRG"},{"name":"COG CRF Text 7","type":"Alternate Question Text","description":"Does patients have CNS1 or CNS2 status and no clinical signs or neurologic symptoms suggestive of CNS leukemia, such as cranial palsy?","url":null,"context":"COG"}],"origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7BD8A964-EFA6-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-12-29","modifiedBy":"KUMMEROA","dateModified":"2023-03-06","changeDescription":"Replaced VD Eligibility Ind-2 2018257v1 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"2023.3.6 AQT added per ticket request CADSR0002119. ak 2022.12.20 AQT added for ticket request CADSR0001812. ak 2022.11.15 AQT added for ticket request CADSR0001687. ak 10/7/22 added AQT for COG cjl;","unresolvedIssues":null,"deletedIndicator":"No"}}